You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alirocumab

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Extra Alirocumab in Addition to Statin Therapy in Symptomatic

Recruiting
  • Stroke
  • Intracranial Atherosclerotic Stenosis
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Sep 24, 2023

Intracranial Atherosclerosis, Atherosclerotic Plaque, Stenosis Trial in Nanjing (Alirocumab, Atorvastatin)

Not yet recruiting
  • Intracranial Atherosclerosis
  • +2 more
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Oct 10, 2023

Nephrotic Syndrome Trial in Dallas (Alirocumab, Alirocumab , Atorvastatin)

Terminated
  • Nephrotic Syndrome
  • Alirocumab
  • +2 more
  • Dallas, Texas
    DallasVAMC
Aug 17, 2022

Familial Hypercholesterolemia Trial in Madrid (Alirocumab)

Completed
  • Familial Hypercholesterolemia
  • Alirocumab
  • Madrid, Spain
    Fundacion Hipercolesterolemia Familiar
Jul 15, 2022

Sepsis Trial in Atlanta (Alirocumab, Placebo)

Not yet recruiting
  • Sepsis
  • Alirocumab
  • Placebo
  • Atlanta, Georgia
  • +1 more
Jul 19, 2022

Alcohol Associated Liver Disease, Heavy Drinking Behavior Trial run by the NIAAA (Alirocumab, Placebo)

Recruiting
  • Alcohol Associated Liver Disease
  • Heavy Drinking Behavior
  • Alirocumab
  • Placebo
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Cardiac Allograft Vasculopathy Trial in Brno, Prague (Alirocumab, Placebo)

Recruiting
  • Cardiac Allograft Vasculopathy
  • Alirocumab
  • Placebo
  • Brno, Czechia
  • +1 more
Apr 26, 2022

Stroke, Acute Ischemic, PCSK9 Inhibitor Trial in Seoul (Alirocumab)

Not yet recruiting
  • Stroke, Acute Ischemic
  • PCSK9 Inhibitor
  • Alirocumab
  • Seoul, Korea, Republic of
    Asan Medical Center
Oct 9, 2023

Coronary Vessel, Coronary Circulation, Atheroma; Myocardial Trial in Worldwide (Alirocumab)

Completed
  • Coronary Vessel
  • +2 more
  • Alirocumab
  • Wien, Austria
  • +8 more
Feb 23, 2022

Intracranial Atherosclerosis, Acute Ischemic Stroke, ICAS - Intracranial Atherosclerosis Trial in Chiayi City (Alirocumab)

Recruiting
  • Intracranial Atherosclerosis
  • +2 more
  • Alirocumab
  • Chiayi City, Taiwan
    Yenchu Huang
Nov 29, 2022

Acute Myocardial Infarction Trial in Shanghai (alirocumab, conventional treatment)

Recruiting
  • Acute Myocardial Infarction
  • alirocumab
  • conventional treatment
  • Shanghai, Shanghai, China
  • +3 more
Oct 31, 2022

Type2 Diabetes Trial in Nantes (Alirocumab, Placebo)

Recruiting
  • Type2 Diabetes
  • Alirocumab
  • Placebo
  • Nantes, France
    University Hospital of Nantes
Jan 12, 2021

Homozygous Familial Hypercholesterolemia Trial in Worldwide (Alirocumab, Placebo)

Completed
Has Results
  • Homozygous Familial Hypercholesterolemia
  • Alirocumab
  • Placebo
  • Boca Raton, Florida
  • +27 more
Jun 7, 2021

Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia Trial in Canada, United States (Alirocumab, Placebo Matched to

Completed
Has Results
  • Hypercholesterolemia
  • Heterozygous Familial Hypercholesterolemia
  • Alirocumab
  • Placebo Matched to Alirocumab
  • Mission Viejo, California
  • +13 more
Jul 19, 2020

Hypercholesterolemia Trial in France, United States (Alirocumab, Placebo)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • Placebo
  • Salt Lake City, Utah
  • +3 more
Jun 4, 2020

Heterozygous Familial Hypercholesterolemia Trial in Germany, United States (Placebo, Alirocumab)

Completed
Has Results
  • Heterozygous Familial Hypercholesterolemia
  • Placebo
  • Alirocumab
  • Aurora, Colorado
  • +12 more
Apr 21, 2020

Acute Coronary Syndrome, Premature Coronary Heart Disease, Lipoproteinemia Trial in Ljubljana (Alirocumab, Evolocumab, Control

Unknown status
  • Acute Coronary Syndrome
  • +4 more
  • Alirocumab
  • +2 more
  • Ljubljana, Slovenia
    University Medical Centre Ljubljana-Department of Vascular disea
Oct 27, 2020

Myocardial Infarction, Hypercholesterolemia Trial in Richmond (alirocumab, )

Completed
Has Results
  • Myocardial Infarction
  • Hypercholesterolemia
  • alirocumab
  • placebo
  • Richmond, Virginia
    Virginia Commonwealth University
Aug 15, 2019

Stroke, Intracranial Atherosclerosis, Intraplaque Hemorrhage Trial in Salt Lake City (Alirocumab, Placebo)

Terminated
  • Stroke
  • +2 more
  • Alirocumab
  • Placebo
  • Salt Lake City, Utah
    University of Utah
Apr 18, 2020

Hypercholesterolemia Trial in Worldwide (Atorvastatin, Ezetimibe, Alirocumab)

Completed
Has Results
  • Hypercholesterolemia
  • Anaheim, California
  • +69 more
Jun 10, 2020

Atherosclerosis, Hyperlipidemia Trial in Beverly Hills (Alirocumab)

Unknown status
  • Atherosclerosis
  • Hyperlipidemia
  • Alirocumab
  • Beverly Hills, California
    Westside Medical Associates of Los Angeles
Apr 24, 2019

Hypercholesterolemia Trial in Worldwide (Alirocumab, Rosuvastatin, Ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +3 more
  • Chandler, Arizona
  • +92 more
Mar 26, 2020

Hypercholesterolemia Trial in China, India, Thailand (Alirocumab, Placebo for alirocumab, ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +6 more
  • Beijing, China
  • +61 more
Sep 9, 2019

Myocardial Infarction, Dyslipidemias Trial in United Kingdom (Alirocumab, Atorvastatin 80mg, Ezetimibe 10mg)

Withdrawn
  • Myocardial Infarction
  • Dyslipidemias
  • Alirocumab
  • +2 more
  • Exeter, Devon, United Kingdom
  • +16 more
Jun 11, 2019

Atherosclerosis, Coronary Heart Disease Trial in Saint Louis (Alirocumab, Placebos)

Completed
  • Atherosclerosis
  • Coronary Heart Disease
  • Alirocumab
  • Placebos
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 5, 2018